Aurinia Pharmaceuticals Inc (AUPH)
Nasdaq: AUPH · Pharmaceutical Preparations · Edmonton, AB · filing with the SEC since 2014
Grade6.8
◀ Past 8.2● Present 6.8▶ Future 5.5
Who owns Aurinia Pharmaceuticals Inc
As filed with the SECHolders of 5% or more
1
Tang Capital Management, LLC holds 10% of Common Shares, no par value, as its SCHEDULE 13D/A filed Jun 4, 2026 says.
Directors and officers
12
report now, of 29 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Tang Capital Management, LLC
SCHEDULE 13D/A · filed Jun 4, 2026 · Common Shares, no par value · 9.2% in Mar 25, 2026
Armistice Capital, LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common shares, no par value · reported falling below 5%
Chin Kyu Huh
SCHEDULE 13D/A · filed Aug 26, 2026 · Common Shares, no par value · reported falling below 5%, from 5% in Aug 13, 2025
What AUPH reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
2sales
11purchases
0sales on a scheduled plan
1people selling
$500,000sold, in dollars
$25.1Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 30 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Robertson Stephen P. | Chief Legal Officer | 2 | $500,000 | 0 | 0 | $0 |
| Tang Kevin | Chief Executive Officer | 0 | $0 | 0 | 11 | $25.1M |